Definitive Price To Sales Ratio from 2010 to 2025
| DH Stock | USD 2.81 0.02 0.72% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 1.90082217 | Current Value 1.81 | Quarterly Volatility 33.24429406 |
Check Definitive Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definitive Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 57.5 M, Interest Expense of 15.9 M or Selling General Administrative of 38.6 M, as well as many indicators such as Price To Sales Ratio of 1.81, Dividend Yield of 0.0104 or PTB Ratio of 0.75. Definitive financial statements analysis is a perfect complement when working with Definitive Healthcare Valuation or Volatility modules.
Definitive | Price To Sales Ratio |
Latest Definitive Healthcare's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Definitive Healthcare Corp over the last few years. Price to Sales Ratio is figured by comparing Definitive Healthcare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Definitive Healthcare sales, a figure that is much harder to manipulate than other Definitive Healthcare Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Definitive Healthcare's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definitive Healthcare's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.26 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Definitive Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 51.22 | |
| Geometric Mean | 29.07 | |
| Coefficient Of Variation | 64.91 | |
| Mean Deviation | 30.34 | |
| Median | 75.49 | |
| Standard Deviation | 33.24 | |
| Sample Variance | 1,105 | |
| Range | 73.6791 | |
| R-Value | (0.86) | |
| Mean Square Error | 303.70 | |
| R-Squared | 0.74 | |
| Significance | 0.000017 | |
| Slope | (6.02) | |
| Total Sum of Squares | 16,578 |
Definitive Price To Sales Ratio History
About Definitive Healthcare Financial Statements
Investors use fundamental indicators, such as Definitive Healthcare's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Definitive Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 1.90 | 1.81 |
Currently Active Assets on Macroaxis
Check out the analysis of Definitive Healthcare Correlation against competitors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.54) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.